Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a Fiber-Fortified biscuit help tame blood sugar spikes?

NCT ID NCT07682857

Knowledge-focused Sponsor: University of Turin, Italy Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This pilot study tests whether a rusk (a type of crisp bread) enriched with arabinoxylan fiber can improve how the body handles sugar after a meal. Ten healthy adults will eat either the fiber-enriched rusk or a standard rusk, and researchers will measure changes in blood glucose, insulin, and appetite-related hormones. The goal is to see if adding this type of fiber to a simple food could help with blood sugar control and feelings of fullness.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
arabinoxylan-enriched rusk (soluble fiber from wheat and barley)
What this could lead to
If it works, this could point toward a simple dietary way to help manage blood sugar and appetite.
What could go wrong
This is a very small pilot study with only 10 healthy volunteers, so results may not apply to the general population or people with health conditions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

10 people

The number who actually took part.

Started

Jan 2025

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * healthy adults; * age 20-65 years; * ability to provide informed written consent. Exclusion Criteria: * obesity; * acute or chronic diseases; * pharmacological therapies or supplements potentially influencing glycemic and/or insulinemic responses; * dietary restrictions; * allergy or intolerance to the tested food

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthy adult participants are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Insulin Resistance

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Healthy adult participants

Contacts and locations

Locations

  • University of Turin

    Torino, Italy, 10126, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.